These findings underscore the intricate relationship between oxidative stress and lipid homeostasis in the progression of atherosclerosis, suggesting that targeting the HO-1/Nrf2 axis could be a promising therapeutic strategy. The gene discussed is HMOX1; the disease is atherosclerosis.